NDA 022510 · Sentynl Theraps INC
Abstral
Fentanyl Citrate · Sublingual
DiscontinuedLast checked: Nov 20, 2026Latest source record: Oct 7, 2019 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2011
Jan 7, 2011
Approved uses
1
Original approval plus efficacy supplements
Registered trials
1,750
243 Phase 3, 113 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jan 7, 2011 Original approval · Type 3 - New Dosage Form ReviewSummary ReviewLabel
6 products under this application
- ABSTRAL · FENTANYL CITRATE EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, SUBLINGUAL · Discontinued
- ABSTRAL · FENTANYL CITRATE EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, SUBLINGUAL · Discontinued
- ABSTRAL · FENTANYL CITRATE EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, SUBLINGUAL · Discontinued
- ABSTRAL · FENTANYL CITRATE EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, SUBLINGUAL · Discontinued
- ABSTRAL · FENTANYL CITRATE EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, SUBLINGUAL · Discontinued
- ABSTRAL · FENTANYL CITRATE EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, SUBLINGUAL · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Fentanyl" as an intervention, any sponsor and status, largest first.
Vanderbilt UniversityAcademic, hospital or other
NCT02625181 · 27,034 participants · Start Jul 2016 · Primary completion Nov 2, 2017
Drug: Propofol; Sevoflurane and 28 more · For: Postoperative Nausea and Vomiting
Sites: Nashville, Tennessee
- Patient-controlled Intravenous Analgesia Combined With Different Opioid Receptors for Gastrointestinal SurgeryPivotal-lookingCompleted
Xijing HospitalAcademic, hospital or other
NCT05576675 · 4,342 participants · Start May 1, 2018 · Primary completion Mar 31, 2022
Drug: sufentanil + nalbuphine; Sufentanil and 1 more · For: Gastrointestinal Surgery
Sites: XIan, China
- Combined Use of Etomidate and Propofol in Painless Gastroscopy.Pivotal-lookingStatus unknown
Jiangsu Nhwa Pharmaceutical Co., Ltd.Industry
NCT01913054 · 2,450 participants (planned) · Start Aug 2013 · Primary completion Dec 2013
Drug: Fentanyl Injection; Etomidate Fat Emulsion Injection and 1 more · For: Safety of Gastroscopy
Sites: Beijing, China; Harbin, China; Wuhan, China · 6 sites in all
- Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer PainPivotal-lookingCompleted
Gachon University Gil Medical CenterAcademic, hospital or other
NCT00478101 · 2,006 participants · Start Feb 2006
Drug: oxycodone fentanyl · For: Advanced Solid Cancers
- Etomidate to Improve Outcome in Elderly PatientsPivotal-lookingCompleted
Zhihong LUAcademic, hospital or other
NCT02910206 · 1,917 participants · Start Aug 15, 2017 · Primary completion Nov 20, 2019
Drug: Etomidate; propofol and 2 more · For: Postoperative Complications
Sites: Xi'an, China
- Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial)Pivotal-lookingRecruiting
Second Affiliated Hospital of Wenzhou Medical UniversityAcademic, hospital or other
NCT06452147 · 1,860 participants (planned) · Start Jun 19, 2024 · Primary completion Jul 30, 2028
Drug: Bupivacaine liposome; Regular local anesthetic and 1 more · For: Anesthesia; Hip Fractures; Dementia and 2 more
Sites: Dongyang, China; Hangzhou, China; Jinhua, China · 13 sites in all
- MAST Trial: Multi-modal Analgesic Strategies in TraumaPivotal-lookingCompleted
The University of Texas Health Science Center, HoustonAcademic, hospital or other
NCT03472469 · 1,561 participants · Start Apr 2, 2018 · Primary completion Jul 3, 2019
Drug: Acetaminophen IV/PO; Acetaminophen PO and 9 more · For: Nonspecific Pain Post Traumatic Injury
Sites: Houston, Texas
- Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal SurgeryPivotal-lookingStatus unknown
Second Affiliated Hospital of Nanchang UniversityAcademic, hospital or other
NCT05624424 · 1,317 participants (planned) · Start Nov 15, 2022 · Primary completion Oct 31, 2023
Drug: Rematazolam Besylate; Propofol and 4 more · For: Emergence Agitation; Remimazolam Besylate; Perioperative Sedation and 2 more
Sites: Ganzhou, China; Jiujiang, China; Nanchang, China · 6 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Comparison of Fentanyl, Remifentanil, Sufentanil and Alfentanil in Combination with Propofol for General Anesthesia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Sridharan K, Sivaramakrishnan G · Curr Clin Pharmacol 2019 · Comparative Study, Meta-Analysis
- Transdermal fentanyl for cancer pain.
Hadley G, Derry S, Moore RA, et al. · Cochrane Database Syst Rev 2013 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Shifting Views on Cancer Pain Management: A Systematic Review and Network Meta-Analysis.
Imkamp MSV, Theunissen M, Viechtbauer W, et al. · J Pain Symptom Manage 2024 · Systematic Review, Network Meta-Analysis
- Intravenous fentanyl PCA during labour.
Nikkola EM, Ekblad UU, Kero PO, et al. · Can J Anaesth 1997 · Clinical Trial, Randomized Controlled Trial
- Safety and effectiveness of adding fentanyl or sufentanil to spinal anesthesia: systematic review and meta-analysis of randomized controlled trials.
Fonseca NM, Guimarães GMN, Pontes JPJ, et al. · Braz J Anesthesiol 2023 · Meta-Analysis, Systematic Review
- [Fentanyl reduces the MAC of sevoflurane].
Zhang Y, Hu X, Zhnag Y · Zhonghua Yi Xue Za Zhi 1999 · Clinical Trial, Randomized Controlled Trial
Sponsor: Sentynl Theraps INC
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.